# MiNK Therapeutics, Inc.: Form 8-K, filed Jun 20, 2023

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2023-06-20
- Accepted by EDGAR: Jun 20, 2023, 19:45 ET
- Period: 2023-06-13
- Accession: 0000950170-23-028900
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/inkt-20230613.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/inkt-20230613.htm

Filed Jun 20, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-028900. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.